| Tumor targeting via EPR: Strategies to enhance patient responses |
185 |
| In situ forming injectable hydrogels for drug delivery and wound repair |
94 |
| Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications |
86 |
| Drug delivery systems and materials for wound healing applications |
66 |
| Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine |
59 |
| 3D bioprinting of tissues and organs for regenerative medicine |
54 |
| Polymeric microneedles for transdermal protein delivery |
50 |
| Perspectives on the past, present, and future of cancer nanomedicine |
48 |
| Imaging and therapeutic applications of persistent luminescence nanomaterials |
48 |
| Thermoresponsive polymer nanocarriers for biomedical applications |
47 |
| Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine |
47 |
| Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers |
45 |
| Aptamer chemistry |
45 |
| 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling |
43 |
| Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing |
42 |
| The biology of mucus: Composition, synthesis and organization |
41 |
| Strategies, design, and chemistry in siRNA delivery systems |
40 |
| 3D printed drug delivery and testing systems - a passing fad or the future? |
40 |
| Nanoparticle-based local antimicrobial drug delivery |
40 |
| Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies |
40 |
| Recent advances of controlled drug delivery using microfluidic platforms |
40 |
| Brief update on endocytosis of nanomedicines |
39 |
| Drug delivery systems for programmed and on-demand release |
38 |
| Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring |
36 |
| Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems |
36 |
| Design strategies for shape-controlled magnetic iron oxide nanoparticles |
35 |
| Clinical applications of the CellSearch platform in cancer patients |
35 |
| Device-assisted transdermal drug delivery |
35 |
| PEGylation for enhancing nanoparticle diffusion in mucus |
33 |
| Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes |
33 |
| Current developments and applications of microfluidic technology toward clinical translation of nanomedicines |
31 |
| Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond |
31 |
| Advanced drug delivery systems and artificial skin grafts for skin wound healing |
31 |
| Recent insights in magnetic hyperthermia: From the hot-spot effect for local delivery to combined magneto-photo-thermia using magneto-plasmonic hybrids |
29 |
| Harnessing albumin as a carrier for cancer therapies |
29 |
| Size-based separation methods of circulating tumor cells |
29 |
| Insulin delivery systems combined with microneedle technology |
29 |
| Cardiac fibrosis - A short review of causes and therapeutic strategies |
29 |
| Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy |
29 |
| Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool |
27 |
| Aptamer-based targeted therapy |
27 |
| Advances in transdermal insulin delivery |
27 |
| Strategic design of extracellular vesicle drug delivery systems |
27 |
| Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery |
27 |
| The role of mucus on drug transport and its potential to affect therapeutic outcomes |
26 |
| Targeting and isolation of cancer cells using micro/nanomotors |
25 |
| Therapeutic strategies for enhancing angiogenesis in wound healing |
25 |
| Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review |
25 |
| Nanocarrier-based systems for targeted and site specific therapeutic delivery |
25 |
| Aptamer-guided nanomedicines for anticancer drug delivery |
24 |
